Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females

Clinical trial NCT02740790 · COMPLETED

Trial details

NCT number: NCT02740790
Sponsor: Shanghai Zerun Biotechnology Co.,Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Human Papillomavirus

Start date: 2013-09-01
Primary completion: 2015-09-01
Enrollment: 1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.